Cardium Therapeutics chooses Criterium, Inc.’s Interactive Voice Response System as a Key Component for Phase 3 Multi-Center (“AWARE”) Cardiovascular Study

Criterium, Inc. today announced that it has been selected by Cardium Therapeutics of San Diego, CA over competing vendors to provide it’s Interactive Voice Response System (IVRS) services for conducting a Phase 3 clinical trial to evaluate the effectiveness of Generx™ (alferminogene tadenovec, Ad5FGF-4) in women for the potential treatment of myocardial ischemia (insufficient blood flow within the heart muscle) which gives rise to the clinical symptom of angina associated with coronary heart disease.

Continue reading

Roopali Tople named Lead Monitor for Criterium India

The establishment of a data management center in the city of Pune, India has been the first step in the successful implementation of a strategy that has enabled Criterium to elevate its global profile and manage even larger amounts of data, while remaining faithful to an “information in real time” philosophy for its clients.

Continue reading